SLDB Stock Analysis: Buy, Sell, or Hold?
SLDB - Solid Biosciences Inc. Common Stock
$7.20
0.71 (10.94%)
▲
5d:
+7.78%
30d:
+16.13%
90d:
+26.54%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Accumulation
SLDB is down 11.5% this week, but smart money is accumulating calls. Top strike: $9 2026-06-18 with 24 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When SLDB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SLDB shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SLDB shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SLDB is currently trading at $7.20, which is considered fair relative to its 30-day fair value range of $6.14 to $7.59.
Technical Outlook: Technically, SLDB is in a strong uptrend. Immediate support is located at $6.40, while resistance sits at $7.96. The stock is showing strong short-term momentum, up 10.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.08 (+137.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLDB is in a strong uptrend. Immediate support is located at $6.40, while resistance sits at $7.96. The stock is showing strong short-term momentum, up 10.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.08 (+137.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.14 -
$7.59
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.9%)
- BULLISH: Trading 137.2% below Wall St target ($17.08)
Fair Price Analysis
30-Day Fair Range
$6.14 -
$7.59
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$6.40
Resistance Level
$7.96
Current Trend
Strong Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.27
Wall Street Target
$17.08
(+137.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 01, 2026 1:08 AM ET
Data refreshes hourly during market hours. Next update: 2:08 AM
Data refreshes hourly during market hours. Next update: 2:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLDB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Howton
SELL
7469 shares
2026-02-18
Ilan Ganot
SELL
2658 shares
2026-02-18
Jessie Hanrahan
SELL
4134 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 49 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 66 BUY |
